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microRNAs and the immune response
Eleni Tsitsiou and Mark A LindsayAlthough the immune response is predominantly controlled
at the transcriptional level, microRNA-mediated RNA
interference is emerging as an important regulatory mechanism
that operates at the translation level. Specifically, recent
studies indicate that those miRNAs that are selectively
and/or highly expressed in immune cells including the
miR-17–92 cluster, miR-150, miR-155, miR-181 and
miR-223 have a ‘permissive’ function in the maturation,
proliferation and differentiation of myeloid and lymphoid cells.
Importantly, these actions of miRNAs often involve interactions
with transcription factors. In contrast, the rapid and transient
induction of miR-9, miR-146a and miR-155 has been
speculated to negatively regulate the acute responses
following activation of innate immune through down-regulation
of proteins involved in the receptor-induced signalling
pathways.
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Introduction
At present, >550 micro (mi)RNAs have been identified
in mammalian cells and are known to regulate mRNA
translation via the RNA interference pathway. These
short RNA sequences of 20–23 nucleotides in length are
produced by the processing of full length mRNA-like
transcripts [1,2]. miRNA biogenesis involves the initial
transcription of primary miRNAs by RNA polymerase
II to produce capped, polyadenylated RNA transcripts.
In the majority of cases these are subsequently recog-
nised and cleaved within the microprocessor complex
that contains the RNase III enzyme Drosha in combi-
nation with DGCR8, to create a hairpin RNA of 65-
nucleotides entitled the precursor microRNA. Precursor
miRNAs are then transported into the cytoplasm by
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produce the duplex miRNA. The Dicer loaded duplex
miRNA is then recruited to argonaute-2 protein by
TRBP (the human immunodeficiency virus transacti-
vating response RNA-binding protein) to form the
miRNA-induced silencing complex (miRISC) where
one strand (often called the passenger strand or *
strand) is cleaved to leave the single-stranded mature
miRNA (often called the guide strand). At present,
miRNAs are believed to either repress mRNA trans-
lation or reduce mRNA stability following imperfect
binding between the miRNA and the miRNA-recog-
nition elements (MRE) within the 30 untranslated
region (UTR) of target genes. Specificity of the micro-
RNA is thought to be mediated by the ‘seed’ region,
that is localised between residues 2–8 at the 50 end.
However, this is influenced by factors such as the
presence and cooperation between multiple MREs,
the spacing between MREs, proximity to the stop
codon, position within the 30 UTR, AU composition
and target mRNA secondary structure [3].
The first indication that miRNAs might regulate the
immune responses was a report in 2004 showing se-
lective expression of miR-142a, miR-181a and miR-223
in immune cells [4]. In this study, miR-181a was found
to be localised in B-lymphocytes, miR-142a in B-
lymphocytes and myeloid cells whilst miR-223 was
confined to myeloid cells. Since this initial observation,
miRNAs have been implicated in the regulation of
maturation, proliferation, differentiation and activation
of immune cells. In this review, we briefly describe the
recent studies that have examined the function of
miRNAs in the innate and acquired immune response
[5–7].
Innate immune response
The innate immune response provides the initial defence
against infection by external pathogens and is predomi-
nantly mediated via myeloid cells such as macrophages,
dendritic cells, monocytes and neutrophils. The presence
of pathogens is commonly detected by tissue macro-
phages and dendritic cells via families of pattern recog-
nition receptors that bind conserved molecules within
bacteria, fungi and viruses. Many families of pattern
recognition receptors have been identified although the
best characterised are the Toll-like and interleukin-1
receptors (TIRs). As the name implies, the TIRs can
be subdivided into the Toll-like receptors (TLR) that are
composed of 11members (namedTLR-1 toTLR-11) and
the interleukin (IL)-1 receptors that have 10 members
(Figure 1).www.sciencedirect.com
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Figure 1
Overview of the role of miR-9, miR-146a and miR-155 during activation of the innate immune responses. The illustration summarises the mechanisms
that regulate the induction and action of miR-9, miR-146a and miR-155 following activation of the Toll-like/interleukin-1 receptor superfamily.
Abbreviations: IL, interleukin; IFN, interferon; IRAK, IL-1 receptor activated kinase; IRF, interferon regulatory factor; JNK, c-jun N-terminal kinase; NF,
nuclear factor; TAB, TAK-1 binding protein; TAK, Toll activated kinase, TLR, Toll-like receptor; TNF, tumour necrosis factor; TRAF, TNF receptor
associated factor.miR-9, miR-146a and miR-155 regulate the activation of
myeloid cells
Recent investigations in macrophages, monocytes, neu-
trophils, epithelial cells and in whole animal studies have
shown that the activation of TIRs and TNFa receptor
results in rapid expression of a host of miRNAs including
let-7, miR-9, miR-99b, let-7e, miR-125a, miR-132, miR-
146a, miR-146b, miR-155, miR-187 and miR-223
[8,9,10–13] (Figure 1). Of these miRNAs, only miR-
146a and miR-155 appear to be induced in multiple cell
types. Studies into the mechanism of LPS-induced miR-
9, miR-146a and miR-155 expression demonstrate a cen-
tral role of the pro-inflammatory transcription factor
nuclear factor (NF)-kB [8,11,13]. However, signalling
through the c-jun-N-terminal kinase (JNK) also appears
to regulate poly I:C (TLR-3) and TNFa-induced miR-
155 expression in murine macrophages [9]. Examinationwww.sciencedirect.comof the targets of these miRNAs has shown them to down-
regulate proteins involved in the TIR signalling pathway
including nuclear factor-kB1 (NF-kB1) (miR-9), tumour
receptor factor associated factor-6 (TRAF6) (miR-146a),
IL-1 receptor activated kinase-1 (IRAK1) (miR-146a),
TAB2 (miR-155), Fas-associated death domain protein
(miR-155), IkB kinase e (IKKe) (miR-155) and receptor
interacting serine–threonine kinase 1 (Ripk1) (miR-155)
[8,9,11,13]. This observation has led to the speculation
that miR-9, miR-146a and miR-155 might negatively
regulate TIR-induced responses associated with the
innate immune response although there is presently little
experimental evidence to support that contention. Inter-
estingly, our own studies examining the effect of inhibi-
tors and mimics of miR-146a upon the IL-1b-induced in
alveolar A549 epithelial cells have shown that miR-146a
negatively regulates chemokine release but not throughCurrent Opinion in Pharmacology 2009, 9:514–520
516 Immunomodulationdown-regulation of TRAF6, IRAK1 or other protein
involved in the IL-1b signalling pathway [14].
miR-155, miR-223 and the miR-17–19 cluster regulate
myeloid proliferation and differentiation
In addition to their role in the acute response to patho-
gens, miR-155, miR-223 and the miR-17–92 cluster have
also been implicated in myeloid proliferation and differ-
entiation. A role for miR-155 was first suggested from the
examination of bone marrow myeloid cells obtained from
LPS exposed mice [15]. Additional support for a role in
proliferation was obtained from the studies of enforced
miR-155 expression in haematopoietic stem cells that
produced a myoproliferative disorder similar to acute
myeloid leukaemia (AML). Microarray analysis indicated
that the actions of miR-155 were mediated through down-
regulation of transcription factor known to regulate hae-
matopoietic development including Cutl1, Arntl, Picalm,
Jarid2, Csf1r, HIF1a, Cebpb, Bach1 and PU.1 (see later)
[15]. Studies in human cord blood CD34+ haematopoietic
progenitor cells induced to differentiate into monocytes
upon exposure to macrophage-colony stimulating factor
(M-CSF) also implicated the miR-17–92 cluster [16].
Under these circumstances, the reduction in miR-17–
92 expression led to an increase in the transcription factor
acute myeloid leukaemia-1 (AML1), the DNA-binding
subunit of the haematopoietic transcription factor core-
binding factor (CBF), which caused expression of genes
involved in myeloid cell differentiation [16].
In contrast to miR-155 and the miR-17–92 cluster, miR-
223 negatively regulates the proliferation and differen-
tiation of neutrophils through down-regulation of the
transcription factor Mef2c, a known promoter of myeloid
progenitor proliferation. This conclusion is based upon
observations in a miR-223 knockout mouse, which
demonstrated increased neutrophil numbers, spon-
taneous inflammation in the lung and exaggerated tissue
destruction following LPS challenge [17]. Interestingly, it
appears that miR-223 is selectively expressed in neutro-
phils and macrophages but not monocytes and lympho-
cytes and this process is regulated by competitive binding
between transcription factors. Thus, increased miR-223
expression results from the displacement of the inhibitor
NFI-A by two stimulatory transcription factors, C/EBPa
and PU.1 [18,19]. Significantly, this process is driven by
themiR-223-mediated down-regulation in NFI-A protein
expression [18,19].
Acquired immune response
The acquired immune response involves the selective
recognition and removal of invading pathogens by the T-
cell receptors and antibodies expressed by T-lympho-
cytes and B-lymphocytes, respectively. The maturation
(production of TCR and antibodies), proliferation, differ-
entiation and activation of lymphocytes involve multiple
compartments and a complex and tightly controlled path-Current Opinion in Pharmacology 2009, 9:514–520way (Figures 2 and 3). This has meant that the majority of
the studies looking into the role of miRNAs in the
acquired immune response have been performed in
knockout and transgenic mice.
DICER knockout mice demonstrates a role of miRNAs in
T-cells
Initial studies into the role of miRNAs in the acquired
immune response involved the knockout of DICER, an
RNase III enzyme, that is crucial to the production of
mature miRNAs (Figure 2). Dicer knockout during early
development (prior to DN3) showed that miRNAs were
not required for CD4+ and CD8+ T-cells lineage commit-
ment but were crucial for T-cell proliferation that was
reflected in the 90% reduction in circulating cells [20]. At
least part of the action of DICER knockout appears to be
mediated through loss of the miR-17–92 miRNA cluster
that targets down-regulation of the pro-apoptotic protein,
Bim and the tumour suppressor, PTEN [21]. Thus,
conditional over-expression of this cluster of seven miR-
NAs (miR-17-5p, miR-17-3p, miR-18a, miR-19a, miR-
20a, miR-19b and miR-92) at the DN1 stage resulted in
auto-immunity that was characterised by enhanced T-cell
proliferation and survival, particular effector CD4+ T-
cells. Dicer knockout at the later stages of T-cell matu-
ration (DN/DP transition) showed that miRNAs were
required for the generation of CD4+ Treg cells and
Th2 phenotype [22,23]. The importance of miRNAs in
FoxP3+CD4+Treg development and immunosuppressive
activity has been confirmed by FoxP3 driven deletion of
DICER which results in mice that die of spontaneous
inflammation and autoimmune disease [24–26].
miR-155 and miR-181a regulate T-cell response
Although the DICER knockout studies have indicated
that miRNAs are important in maintaining the T-cell
driven immune response, with the exception of miR-155
and miR-181a much less is known regarding the role of
individual miRNAs. Observations in miR-155 knockout
animals have shown that these animals are healthy but are
unable to mount an acquired immune response [27,28].
The role of miR-155 is still uncertain although it would
appear that miR-155 is important in both the T-cell and
B-cell-mediated response. Examination of the profile of
T-cell expression in miR-155 knockout mice show intrin-
sic bias towards Th2 phenotype which results from
increased expression of the Th2 cytokines and the tran-
scription factor, c-maf [27,28]. Interestingly, recent
studies have shown that the transcriptional factor FoxP3,
that is required for differentiation into CD4+ Treg cells,
also induced miR-155 expression. Subsequent analysis
using miR-155 knockout animals has established that
miR-155 is required for the differentiation and prolifer-
ation but not the immunosuppressive action of CD4+
Treg cells [29,30]. Mechanistic studies indicate that
miR-155 down-regulates the protein suppressor of cyto-
kine signalling 1 (SOCS1) which promotes competitivewww.sciencedirect.com
microRNAs and the immune response Tsitsiou and Lindsay 517
Figure 2
Overview of the role of miRNAs during the maturation, activation and differentiation of T-lymphocytes. The illustration summarises the role of miRNAs
in the regulation of T-lymphocytes. Because nothing is known of the role of miRNAs in the development of memory T-cells and other T-cells subtypes,
these have been omitted. Abbreviations: CD, cluster designation; DN, double negative; DP, double positive; PTEN, phosphatase and tensin
homologue.fitness and increased proliferation through the IL-2 and
STAT5 signalling pathways [29] (Figure 2).
The original report by Chen et al. showing that miRNAs
are differentially expressed in immune cells also showed
that over-expression of miR-181a is associated with a
reduction in CD8+ T-cells [4]. A recent report has shown
that increased expression of miR-181a but not miR-181c
is involved in the production of CD4+ and CD8+ double-
positive (DP) T-cells [31]. Intriguingly, the differential
actions of miR-181a and miR-181c resulted from differ-
ences in the stem loop of the pre-miRNAs and not from
the one nucleotide change in the guide sequences of
miRNAs [31].
Both miR-155 and miR-181a have also been implicated in
the regulation of acute response following activation of
CD4+ T-cells. Comparison of the response in CD4+ T-
cells obtained from normal and knockout mice indicates
that miR-155 was required for the release of cytokines
such as IL-2 and IFNg [27]. Similarly, the changes in thewww.sciencedirect.comexpression of miR-181a, which are increased during T-
cell maturation (DN1–3) before dropping in CD4+ and
CD8+ T-cells, have also been shown to modulate TCR
signalling [32]. In this case, elevated miR-181a levels
increased the strength and lowered the threshold
required for TCR signalling in CD4+ T-cells through
coordinated down-regulation of the tyrosine phospha-
tases, Src homology 2 domain-containing protein-tyrosine
phosphatase (SHP)-2 and protein-tyrosine phosphatase
(PTP)-N22, and the ERK-specific, dual specificity phos-
phatases (DUSP)-5 and DUSP-6 [32].
DICER knockout mice demonstrate a role of miRNAs in
B-cell function
The ablation of DICER in early B-cells maturation was
shown to block the pre-B-cell to pro-B-cell transition
resulting in a reduction in the number of B-cells [33]
(Figure 3). As with T-cells, this blockage appeared to be
partly mediated through reduction in the expression of
the miR-17–92 cluster which results in the increased
expression of its targets, the pro-apoptotic protein BimCurrent Opinion in Pharmacology 2009, 9:514–520
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Figure 3
Overview of the role of miRNAs during the maturation, activation and the differentiation of B-lymphocytes. The illustration summarises the role of
miRNAs in the regulation of B-lymphocytes. Abbreviations: Ig, antibody; PTEN, phosphatase and tensin homologue.and the tumour suppressor, PTEN [21,33,34]. Over-
expression of miR-150 which is normally increased during
the maturation of both T-cell and B-cell has also been
shown to block the pro-B-cell to pre-B-cell transition
although this had no effect upon the formation of either
CD4+ and CD8+ T-cells or myeloid cells [35]. The
examination of antibody production in DICER knockout
animals showed intact Ig gene rearrangements in immu-
noglobulin heavy (IgH) and kappa chain loci, but
increased sterile transcription and usage of D(H)
elements of the DSP family in IgH, and increased N
sequence addition in Igk because of deregulated tran-
scription of the terminal deoxynucleotidyl transferase
gene [33].
miR-155 regulates the B-cell response
The availability of knockout and transgenic mouse
models has also established the importance of miR-
155 in B-cell-mediated antibody production and immu-
nity [27,28]. Although these animals have normal cir-
culating B-cell numbers, they were found to be immuno-
deficient, had reduced numbers of germinal centre B-
cells and failed to develop an immune response to
pathogens following immunisation [27,28]. These
defective responses appear to be mediated throughCurrent Opinion in Pharmacology 2009, 9:514–520the involvement of miR-155 in B-cell production of high
affinity IgG1 antibodies, the development of B-cell
memory and the production of cytokines such as TNFa
and lymphotoxin-a/b [28,36]. Mechanistic studies have
shown that the reduction of IgG1 switching is partly
mediated through increased expression of the transcrip-
tion factor PU.1, which has been identified as a direct
target of miR-155 [36] (Figure 3). Recent studies have
also identified the activation-induced cytidine deami-
nase (AID) as a target of miR-155 [37,38]. This enzyme
catalyses the deamination of cytosine residues and intro-
duction of U:G mismatches, that is required for the
generation of the secondary antibody repertoire through
somatic hypermutation, gene conversion and class
switching from IgM to IgG1 [37,38]. Examination of
the role of miR-155 targeting of AID through disruption
of a miR-155 binding site in its 30 UTR resulted in
elevated levels of AID mRNA and protein, an increase
in class switching of IgM to high affinity IgG1, elevated
Myc–Igh translocations but had no effect upon somatic
hypermutation [37,38]. Studies in isolated mouse
spleen B-cells have shown that activation via BCR or
LPS increased miR-155 expression via an NFAT/calci-
nerin and NF-kB dependent pathway, respectively [28]
(Figure 3).www.sciencedirect.com
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This review has outlined the recent evidence demonstrat-
ing the importance of miRNAs in the maturation, pro-
liferation, differentiation and activation of the immune
response. Significantly, these reports suggest that
miRNA-mediated RNA interference regulates the
immune response through the selective expression of a
range of miRNAs including miR-146a, miR-155, miR-
181a and miR-223. However, in order to appreciate the
role of miRNAs in the immune system, it is important to
place this in the context of the complex and coordinated
changes at the transcription level. Thus, unlike transcrip-
tion factors that generally drive protein production, miR-
NAs are thought to inhibit mRNA expression and thereby
eliminate unwanted proteins. Given this observation,
miRNAs could be described as having a ‘permissive’
function during the maturation, proliferation and differ-
entiation of the immune cells. As an example, studies in
DICER knockout animals have indicated that expression
of the miR-17–92 cluster ‘permits’ the proliferation of T-
cell and B-cell through down-regulation of the pro-apop-
totic proteins, Bim and the tumour suppressor, PTEN
[21,33,34]. Interestingly, when the expression of these
miRNAs changes during development these act like
rheostats to control immune responses. Thus, the chan-
ging expression of miR-181a expression during T-cell
maturation has been shown to control the threshold
and strength of signalling during antigen–TCR inter-
action through down-regulation of multiple protein phos-
phatases [32].
As might be expected from the changing transcriptional
profile, another important observation from recent studies
is that the targets and function of individual miRNAs
appear to be dependent upon cellular context, that is
miRNAs can only target mRNA that has been tran-
scribed. Thus, studies of miR-155 in transgenic and
knockout mice have shown that miR-155 regulated the
development of Treg through down-regulation of SOCS1
[29,30], B-cells antibody class switching through down-
regulation of AICD [37,38] and myeloid proliferation
and differentiation via down-regulation of multiple tran-
scription factors [15].
In contrast to the maturation, proliferation and differen-
tiation phases, it has been speculated that the rapid (and
reversible) changes in miRNA expression observed
during activation of the innate and acquired immune
response are involved in negative and positive regulation
of the associated inflammatory responses. Thus, examin-
ation of the TIR-induced response has shown increased
miR-9, miR-146a and miR-155 expression and sub-
sequent down-regulation of proteins involved in the
TIR signalling pathway [8,9,10–13]. Unfortunately,
these reports have not examined the functional con-
sequences either of the changes in miRNA expression
and whether this is linked to down-regulation of the TIR-www.sciencedirect.comsignalling pathway. In addition, studies will also need to
determine the relationship between miRNAs and
multiple negative feedback pathways that are known to
regulate TIR-induced responses including the release of
anti-inflammatory mediators. Of note, a recent report has
suggested that increased miR-106a expression in acti-
vated Jurkat T-cells is responsible for the down-regula-
tion of the anti-inflammatory cytokine, IL-10 [39].
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